Generating 3D Spheres and 2D Air-Liquid Interface Cultures of Human Induced Pluripotent Stem Cell-Derived Type 2 Alveolar Epithelial Cells
April 15th, 2022
7.2K views
The present protocol describes human induced pluripotent stem cell-derived type 2 alveolar epithelial-like cells (iAT2s). These cells can be cultured as self-renewing spheres in 3D culture or adapted to air-liquid interface (ALI) culture.
Overview
This protocol outlines a method for culturing human induced pluripotent stem cell-derived type 2 alveolar epithelial-like cells (iAT2s) in both 3D culture and air-liquid interface (ALI) culture. This technique allows for the investigation of lung biology in the context of homeostasis and disease.
Key Study Components
Area of Science
- Cell culture techniques
- Lung biology
- Pulmonary disease research
Background
- iAT2s are crucial for studying lung function and diseases.
- They can be cultured as self-renewing spheres or in ALI conditions.
- This method aids in understanding the impact of various factors on lung health.
- It provides a platform for environmental exposure studies.
Purpose of Study
- To establish a reliable method for culturing iAT2s.
- To investigate the effects of genetic and environmental factors on lung health.
- To facilitate research on pulmonary diseases affecting alveoli.
Methods Used
- Passaging of iAT2 cells using dispase and trypsin.
- Generation of alveolospheres in a 3D matrix.
- Culture of cells in air-liquid interface conditions.
- Measurement of transepithelial electrical resistance for barrier integrity.
Main Results
- Successful generation of iAT2 cells in both 3D and ALI cultures.
- Maintenance of surfactant protein C expression in cultured cells.
- Demonstration of cell viability and integrity of the air-liquid interface.
- Insights into the effects of environmental factors on alveolar epithelium.
Conclusions
- This technique enhances the understanding of lung biology.
- It opens avenues for research on pulmonary diseases.
- Future studies can explore the impact of various exposures on lung health.
Frequently Asked Questions
What are iAT2 cells?
iAT2 cells are induced pluripotent stem cell-derived type 2 alveolar epithelial-like cells used for lung research.
How are iAT2 cells cultured?
They can be cultured in 3D matrices or air-liquid interface conditions to study lung biology.
What is the significance of the air-liquid interface?
The air-liquid interface mimics the physiological conditions of the lung, allowing for better study of alveolar function.
What are the applications of this protocol?
This protocol can be used to investigate pulmonary diseases and the effects of environmental exposures.
How is cell viability assessed?
Cell viability can be assessed through various methods, including transepithelial electrical resistance measurements.
What factors can affect iAT2 cell culture?
Factors such as mechanical pipetting and enzymatic digestion can impact cell viability and culture outcomes.
Executive Industry Relevance
Human iPSC-derived type 2 alveolar epithelial cell (iAT2) cultures provide a scalable, reproducible platform for modeling lung biology and disease mechanisms relevant to drug discovery. The ability to generate both 3D spheres and 2D air-liquid interface (ALI) cultures enables predictive interrogation of genetic, environmental, and pharmacological perturbations in a physiologically relevant context. This system addresses the critical bottleneck of limited primary human AT2 cell supply, supporting translational research and early-stage portfolio decisions in respiratory therapeutics.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables mechanistic studies of AT2 cell function and dysfunction in disease-relevant systems.
- Supports genetic variant interrogation and pathway de-risking for target validation.
- Facilitates hypothesis-driven exploration of surfactant biology and alveolar repair mechanisms.
Screening & Assay Development
- Provides a renewable source of standardized human alveolar cells for assay development.
- Supports quantitative readouts such as surfactant protein expression and barrier integrity.
- Enables reproducible compound screening in both 3D and ALI formats.
Translational & Preclinical Research
- Models environmental exposures and infectious agents in a human-relevant alveolar context.
- Aligns with translational biomarker strategies through maintenance of AT2-specific markers.
- Supports continuity from discovery through preclinical validation of respiratory drug candidates.
Pipeline & Workflow Integration
This platform integrates into the discovery-to-preclinical continuum by enabling hypothesis testing, assay development, and translational modeling of lung disease mechanisms.
- Discovery Biology: Supports null hypothesis testing for AT2 function and injury mechanisms.
- Screening: Delivers assay-ready, reproducible cultures for quantitative evaluation of compounds and exposures.
- Analytics: Provides outputs such as transepithelial electrical resistance and surfactant protein expression for comparative analysis.
- Translational Research: Bridges in vitro findings to preclinical models via disease-relevant human cell systems.
- Enterprise Reuse: Offers a scalable, renewable platform adaptable across multiple respiratory research programs.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in lung disease modeling.
- Operational Value: Standardizes workflows and enables high-throughput, reproducible experimentation.
- Strategic Value: Improves go/no-go decision-making and reduces late-stage biological risk in respiratory portfolios.
- Portfolio Impact: Supports risk-adjusted prioritization and advancement of respiratory drug candidates.
Implementation Considerations
- Requires expertise in stem cell culture and differentiation protocols.
- Needs access to specialized matrices, cell culture inserts, and analytical instrumentation for barrier and marker assessment.
- Demands rigorous cross-team standardization to ensure reproducibility and data comparability.
- Adaptation may be needed for specific disease models or compound classes.
- Cell viability and differentiation state must be carefully monitored to avoid confounding results.
Biopharma FAQs
Why is null hypothesis testing critical for iAT2 target validation?
Null hypothesis testing using iAT2 cultures enables rigorous evaluation of AT2-specific functions and responses, supporting confident target validation in disease-relevant human systems. This approach reduces mechanistic ambiguity and informs early portfolio triage for respiratory indications.
How does independent variable isolation in ALI cultures advance discovery?
ALI cultures allow precise control of environmental exposures and compound additions, enabling isolation of independent variables and direct assessment of their effects on alveolar epithelial integrity and function. This supports mechanistic de-risking and robust discovery-stage experimentation.
What do quantitative measurements of transepithelial resistance enable?
Quantitative transepithelial electrical resistance measurements provide objective assessment of barrier integrity in ALI cultures, enabling comparison of experimental conditions and supporting reproducible, data-driven decision-making in assay development and screening.
Why are replication requirements important for cross-functional teams?
Replication of iAT2 culture outputs ensures data reliability and comparability across teams, facilitating cross-functional collaboration in assay development, screening, and translational research. Standardized protocols and reproducible results are essential for enterprise-wide adoption.
What statistical analysis capabilities are needed before implementation?
Robust statistical analysis of quantitative outputs such as cell counts, marker expression, and barrier measurements is required to validate assay performance and interpret experimental results. These capabilities underpin confident advancement of findings into downstream R&D workflows.
